Yilan L. Huang

Luzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Artificial intelligence and extracellular vesicles in oncology: towards tumor diagnosis, prediction, and therapy.

Artificial intelligence and extracellular vesicles in oncology: towards tumor diagnosis, prediction, and therapy.

Journal: Drug delivery
Published: August 13, 2026

Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.

Combination of lonidamine with devimistat induces synergistic antitumor effects in lung cancer via multifaceted disruption of cellular energy metabolism.

Journal: Oncology reports
Published: February 12, 2026

Pleiotropic mechanisms and translational trajectory of SGLT2 inhibitors in sepsis-induced cardiomyopathy: Navigating the evidence hierarchy.

Pleiotropic mechanisms and translational trajectory of SGLT2 inhibitors in sepsis-induced cardiomyopathy: Navigating the evidence hierarchy.

Journal: European journal of pharmacology
Published: January 25, 2026

Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges.

Adipose tissue-targeted drug delivery for treating obesity: current opportunities and challenges.

Journal: Drug delivery
Published: August 22, 2025

Corrigendum to "Construction of enzyme-MOFs composite with carbon dots: A strategy to enhance the activity and increase the growth rate of the enzyme-ZIF-8 composite" [Int. J. Biol. Macromol. 291 (2025) 139985].

Corrigendum to "Construction of enzyme-MOFs composite with carbon dots: A strategy to enhance the activity and increase the growth rate of the enzyme-ZIF-8 composite" [Int. J. Biol. Macromol. 291 (2025) 139985].

Journal: International journal of biological macromolecules
Published: July 30, 2025

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies.

SGLT2 Inhibitors in Combination Therapies for Tumors: A Novel Approach to Synergistic Treatment Strategies.

Journal: Drug design, development and therapy
Published: July 25, 2025

Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma.

Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma.

Journal: Frontiers in immunology
Published: June 24, 2025

The causal association between seven drugs and erectile dysfunction: a Mendelian randomization study.

The causal association between seven drugs and erectile dysfunction: a Mendelian randomization study.

Journal: Therapeutic advances in urology
Published: June 11, 2025

Canagliflozin regulates adipocyte lipolysis in vitro via a SGLT2 independent signaling pathway.

Canagliflozin regulates adipocyte lipolysis in vitro via a SGLT2 independent signaling pathway.

Journal: International journal of obesity (2005)
Published: March 25, 2025

SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.

SGLT2 inhibitors in autoimmune diseases: emerging therapeutic potential and clinical challenges.

Journal: Frontiers in immunology
Published: March 07, 2025

Causal relationship between dietary patterns and the risk of developing chronic renal failure: a Mendelian randomization study.

Causal relationship between dietary patterns and the risk of developing chronic renal failure: a Mendelian randomization study.

Journal: Genes & nutrition
Published: January 02, 2025

Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China.

Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China.

Journal: Scientific reports
Published: December 06, 2024
Showing 1-12 of 48

Last Updated: 09/26/2026